Skip to main content

Market Overview

40 Stocks Moving In Thursday's Mid-Day Session



  • New Concept Energy, Inc. (NYSE: GBR) jumped 81.69 percent to $2.58 after Realty Advisors disclosed a new 2.81 percent stake in the company.
  • Neuronetics, Inc. (NASDAQ: STIM) shares shot up 47 percent to $25.02. Neurostimulation device maker Neuronetics priced its IPO of 5.5 million shares at $17 per share.
  • Tricida, Inc. (NASDAQ: TCDA) gained 45.58 percent to $27.66. Tricida priced its 11.7 million share IPO at $19 per share.
  • BJ's Wholesale Club Holdings, Inc. (NYSE: BJ) shares gained 27.8 percent to $21.73. BJ's Wholesale Club priced its 37.5 million share IPO at $17 per share.
  • Progress Software Corporation (NASDAQ: PRGS) shares jumped 17.5 percent to $40.89 following Q2 results. Benchmark upgraded Progress Software from Sell to Hold.
  • Everquote, Inc. (NASDAQ: EVER) climbed 16.3 percent to $20.94. EverQuote priced its 4.68 million share IPO at $18 per share.
  • PEDEVCO Corp. (NYSE: PED) shares gained 13.4 percent to $2.69 after climbing 659.62 percent on Wednesday.
  • Apogee Enterprises, Inc. (NASDAQ: APOG) rose 11.9 percent to $48.34 following Q1 earnings.
  • The Madison Square Garden Company (NYSE: MSG) rose 10.4 percent to $293.93 after the company disclosed that its board has unanimously approved plans to explore possible spinoff. The company plans to separate sports businesses from live entertainment units to create 2 publicly-traded companies.
  • Cavium Inc (NASDAQ: CAVM) rose 9.1 percent to $86.69. Marvell Technology reported receipt of Chinese regulatory approval for Cavium acquisition.
  • RPM International Inc. (NYSE: RPM) gained 8.8 percent to $58.025 after announcing an agreement with Elliott Management.
  • Youngevity International, Inc. (NASDAQ: YGYI) gained 8.2 percent to $4.1882.
  • Zosano Pharma Corporation (NASDAQ: ZSAN) rose 7.9 percent to $4.10. On Wednesday, Zosano Pharma issued a mid-day press release highlighting added analysis from ZOTRIP study will be present at AHS meeting. BTIG Research initiated coverage on Zosano Pharma with a Buy rating and a $19 price target.
  • B. Riley Financial, Inc. (NASDAQ: RILY) climbed 7.4 percent to $23.15 as the company raised its Q2 guidance.
  • China Internet Nationwide Financial Services Inc. (NASDAQ: CIFS) rose 7.2 percent to $16.18.
  • Marvell Technology Group Ltd. (NASDAQ: MRVL) shares gained 7.1 percent to $21.5375 after the company reported receipt of Chinese regulatory approval for Cavium acquisition.


Check out these big penny stock gainers and losers


  • Arsanis, Inc. (NASDAQ: ASNS) shares dipped 74.6 percent to $4.62 after the company announced plans to discontinue its Phase 2 trial of ASN100.
  • Differential Brands Group Inc. (NASDAQ: DFBG) dropped 33 percent to $3.651. Differential Brands Group shares jumped over 500 percent Wednesday following deal to buy majority of North American unit of Global Brands Group for $1.38 billion.
  • Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) dropped 23.9 percent to $3.4099. Akebia Theraepeutics and Kerx Biopharma announced plans to merge.
  • China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) shares dropped 23.4 percent to $5.40.
  • Akebia Therapeutics, Inc. (NASDAQ: AKBA) fell 23.1 percent to $7.99. Akebia Theraepeutics and Kerx Biopharma announced plans to merge.
  • GMS Inc. (NYSE: GMS) fell 22.2 percent to $24.03 after reporting downbeat Q4 results.
  • Pier 1 Imports, Inc. (NYSE: PIR) shares declined 19.1 percent to $2.4283 after the company reported weak sales for its first quarter. Comps were down 8.2 percent in the quarter. The company sees comps down 6-7 percent in the second quarter.
  • Ability Inc. (NASDAQ: ABIL) shares declined 18.4 percent to $6.62.
  • Xcel Brands, Inc. (NASDAQ: XELB) dropped 18.2 percent to $2.05.
  • Entera Bio Ltd. (NASDAQ: ENTX) fell 13.8 percent to $6.90. Entera Bio priced its 1.4 million share IPO at $8 per share.
  • Medigus Ltd. (NASDAQ: MDGS) fell 13.7 percent to $1.2347. Medigus announced a 1-for-10 reverse stock split effective July 13, 2018.
  • Profire Energy, Inc. (NASDAQ: PFIE) shares dipped 13.1 percent to $4.00 after the company issued weak revenue forecast for the second quarter.
  • Gevo, Inc. (NASDAQ: GEVO) shares fell 13.1 percent to $6.58.
  • TransEnterix, Inc. (NYSE: TRXC) dropped 12.6 percent to $5.10. BTIG Research downgraded Transenterix from Buy to Neutral.
  • Greenpro Capital Corp. (NASDAQ: GRNQ) shares declined 12.4 percent to $8.50.
  • TRANSLATE BIO, INC. (NASDAQ: TBIO) dropped 11.4 percent to $11.52. Translate Bio priced its upsized 9.35 million-share IPO at $13 per share.
  • Rockwell Medical, Inc. (NASDAQ: RMTI) shares dipped 10.2 percent to $4.06.
  • Ascent Capital Group, Inc. (NASDAQ: ASCMA) slipped 10.1 percent to $2.79.
  • Walgreens Boots Alliance, Inc. (NASDAQ: WBA) tumbled 9.6 percent to $59.8975 after, Inc. (NASDAQ: AMZN) struck a blow Thursday with its acquisition of PillPack, an online pharmacy. Walgreens reported better-than-expected results for its third quarter on Thursday.
  • Frontier Communications Corporation (NASDAQ: FTR) fell 9.5 percent to $5.43.
  • Acorn International, Inc. (NYSE: ATV) dropped 9.5 percent to $14.0301.
  • Fred's, Inc. (NASDAQ: FRED) fell 9.3 percent to $1.96.
  • Green Plains Inc. (NASDAQ: GPRE) declined 8.1 percent to $17.75. Stephens & Co. downgraded Green Plains from Overweight to Equal-Weight.
  • McKesson Corporation (NYSE: MCK) fell 6.4 percent to $135.48. McKesson expects Q1 earnings of $2.85 to $2.95 per share.

Related Articles (AKBA + ABIL)

View Comments and Join the Discussion!

Posted-In: Losers Mid-Day MoversNews Movers & Shakers Intraday Update Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at